Rigel Pharmaceuticals, Inc. (RIGL), Synta Pharmaceuticals Corp. (SNTA): Three Horrendous Health-Care Stocks This Week
Many stocks encountered turbulence this week, but few were blown about like several biotech stocks.
Posts Tagged ‘NASDAQ:GILD’
Gilead Sciences, Inc. (GILD)’s Entry Into Cancer Therapy
It is interesting to watch a bio company change tactics and go into an area it hasn't explored before. This, to me, is like watching a child suddenly grow up.
Merck & Co., Inc. (MRK), Clovis Oncology Inc (CLVS), Regulus Therapeutics Inc (RGLS): 3 Stocks to Get on Your Watchlist
I follow quite a lot of companies, so the usefulness of a watchlist to me cannot be overstated.
Pfizer Inc. (PFE), Merck & Co., Inc. (MRK): Where to Invest for More Health-Care Exposure
You have plenty of choices of where to invest your portfolio.
Hedge Funds Are Betting On Gilead Sciences, Inc. (GILD)
Gilead Sciences, Inc. (NASDAQ:GILD) was in 63 hedge funds' portfolio at the end of March. GILD shareholders have witnessed an increase in hedge fund sentiment of late.
Regeneron Pharmaceuticals Inc (REGN), Amgen, Inc. (AMGN), Gilead Sciences, Inc. (GILD): Is College Debt a Drag on These Promising Healthcare Stocks
Some stocks seem to have all the luck, offering the best of both worlds.
Johnson & Johnson (JNJ) Takes a Breather
After a 12-week run of seeing its share price rise for the week, Johnson & Johnson (NYSE:JNJ) stock fell last week.
Bristol Myers Squibb Co. (BMY), Gilead Sciences, Inc. (GILD), Halozyme Therapeutics, Inc. (HALO): 3 Stocks to Watch Ahead of ASCO
At the annual ASCO meeting in Chicago, thousands of health-care researchers and professionals unite to advance cancer treatment.
Amgen, Inc. (AMGN): The Ultimate Biotech Diversification Strategy
You want to invest in biotech. You hear about all the monstrous pops and mini-fortunes that are built overnight.
Amgen, Inc. (AMGN) Stock Checkup for May
I have jokingly referred to Amgen, Inc. (NASDAQ:AMGN) in the past as a "senior citizen" of biotech. The company was founded 33 years ago, making Amgen, Inc.
Hedge Funds Are Betting On Gilead Sciences, Inc. (GILD)
To the average investor, there are a multitude of indicators market participants can use to watch stocks.
Johnson & Johnson (JNJ), Gilead Sciences, Inc. (GILD), AbbVie Inc (ABBV): Watch This HCV Player
Johnson & Johnson (NYSE:JNJ)'s hepatitis C drug, simeprevir, recently received Priority Review status from the FDA.
Bristol Myers Squibb Co. (BMY), Pharmacyclics, Inc. (PCYC): Hedging Against Leukemia
As I noted 11 weeks ago, cancer statistics are both staggering and disappointing.
Infinity Pharmaceuticals Inc. (INFI), Oncothyreon Inc (USA) (ONTY), Synageva BioPharma Corp (GEVA): Three Horrendous Healthcare Stocks This Week
There's one drawback to having the stock market indexes hit record highs yet again: It makes finding truly horrendous health-care stocks for our weekly series much more challenging...
Roche Holding Ltd. (ADR) (RHHBY), Bristol Myers Squibb Co. (BMY): Cancer Meeting Highlights the Good and Bad of the Immune System
Biotech investors rejoice. The ASCO abstracts are here.
Is Gilead Sciences, Inc. (GILD) Still A Buy?
Gilead Sciences, Inc. (NASDAQ:GILD) reported a relatively rare earnings miss in the first quarter on May 2.
UnitedHealth Group Inc. (UNH), Aetna Inc. (AET): The Eight Biggest Health Problems Americans Face
The Centers for Disease Control and Prevention would put heart disease at the top of the list, since it's the leading cause of death in the nation.
Vertex Pharmaceuticals Incorporated (VRTX): What You Need To Know
What's the source of your investment strategy? Many look to great investors like Warren Buffett for guidance on how to invest.
Gilead Sciences, Inc. (GILD): The Heart Of The Matter
Gilead Sciences, Inc. (NASDAQ:GILD) has exploded over the last few years as a powerhouse of anti-viral medications. Its myriad treatments for HIV have brought in $2 billion...
Pfizer Inc. (PFE), Eli Lilly & Co. (LLY) & Other Names To Know: A Full Breakdown
Investing in biotech companies can be intimidating, especially for investors without a science background. But there's hope.
Gilead Sciences, Inc. (GILD), Interactive Brokers Group, Inc. (IBKR): Should You Bet on These High-Growth Stocks?
Proponents of income investing may not like it, but there is nothing like a growth portfolio, portions of which can be sold at higher prices to rival the benefits of a dividend...
Vertex Pharmaceuticals Incorporated (VRTX) Just Jumped & Could Jump Again
Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) have appreciated significantly in 2013 so far, and it seems that the trend might continue for the rest of the year.
Galena Biopharma Inc (GALE), Gilead Sciences, Inc. (GILD): Two Biopharmaceutical Companies Worth Buying
The biotechnology industry had a good time last year and the market expects the trend to continue in 2013 as well.
Celgene Corporation (CELG), Biogen Idec Inc. (BIIB), Gilead Sciences, Inc. (GILD): Don’t Try to Pick the Best Biotech Company
Rising biotech stars Celgene Corporation (NASDAQ:CELG), Biogen Idec Inc. (NASDAQ:BIIB), and Gilead Sciences, Inc.
Microsoft Corporation (MSFT) Weekly Options Active
Microsoft Corporation (NASDAQ:MSFT) – Reporting from CNBC’s David Faber this morning that activist fund ValueAct Capital Management LLC has acquired a $2 billion stake in...
Gilead Sciences, Inc. (GILD) or Biogen Idec Inc. (BIIB)? This Is What the Perfect Biotech Would Look Like
I don't know about you, but I'm pretty stoked for the NFL draft this Thursday.
Gilead Sciences, Inc. (GILD), Visa Inc (V), High-Momentum Stocks, Dividends, and Low Fees
Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you.
Vertex Pharmaceuticals Incorporated (VRTX), Gilead Sciences, Inc. (GILD): The Week, Biotech – Part Two
As I mentioned previously in Part 1, it was an incredibly busy week for the biotech sector.
Merck & Co., Inc. (MRK): It Is Not Worth It
Big pharma companies are massive, complicated beasts.
Under The Hood: An Unheralded Biotech ETF – iShares NASDAQ Biotechnology Index (IBB)
Another day, another set of fresh all-time highs for the major biotechnology ETFs.
Amgen, Inc. (AMGN): The One Biotech Stock Buffett Should Buy
The biotechnology sector can be a land of immense spoils and incredible heartbreak.
3 Horrendous Health-Care Stocks This Week: Rigel Pharmaceuticals, Inc. (RIGL), Achillion Pharmaceuticals, Inc. (ACHN)
The Motley Fool's annual April Fools' Day joke this year focused on the "hugest bubble in history" that is set to explode.
Micron Technology, Inc. (MU), Celgene Corporation (CELG) & The Best-Performing NASDAQ-100 Stocks in Q1
It was generally a great quarter for U.S.
Gilead Sciences, Inc. (GILD), Idenix Pharmaceuticals Inc (IDIX), ZIOPHARM Oncology Inc. (ZIOP), Vanguard Health Systems, Inc. (VHS): 3 Horrendous Health-Care Stocks This Week
Have you checked your 401(k) or IRA balance lately? If you're like many people, the numbers brought forth a smile, with the major indexes hitting record highs.
Teva Pharmaceutical Industries Ltd (ADR) (TEVA): Is Amgen, Inc. (AMGN) a Cash King?
In this series, we'll highlight four companies in an industry, and compare their "cash king margins" over time, trying to determine which has the greatest likelihood of putting...
Gilead Sciences, Inc. (GILD), Celgene Corporation (CELG): Is This the Next Investing Bubble?
With the Nasdaq Biotechnology Index hitting record highs, Motley Fool health care analyst Max Macaluso and Fool contributor Brian Orelli sat down to chat about whether we're in...
Hedge Funds Are Betting On Gilead Sciences, Inc. (NASDAQ:GILD)
In today’s marketplace, there are many metrics investors can use to track publicly traded companies.
Is Bristol-Myers Squibb Co. (BMY) One of the Best Companies in America?
The Motley Fool recently published its list of The 25 Best Companies in America and while Bristol-Myers Squibb Co.
This Week in Biotech: Gilead Sciences, Inc. (GILD), GlaxoSmithKline plc (ADR) (GSK)
With the SPDR S&P Biotech Index up 31% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
There Is Potential in This Highly Lucrative Industry: Gilead Sciences, Inc. (GILD), Bristol Myers Squibb Co. (BMY), Johnson & Johnson (JNJ)
Gilead Sciences, Inc. (NASDAQ:GILD) is the world’s foremost biopharmaceutical company when it comes to combating deadly virus.
How Sequestration Will Affect the Health-Care Sector and Your Pocketbook: Gilead Sciences, Inc. (GILD), Life Technologies Corp. (LIFE)
Stop me if you've heard this joke before: "Two political parties walk into a bar; both point the finger at each other for the country's fiscal mess, yet neither is willing to ...
The Perfect Cure for Hepatitis C? – Gilead Sciences, Inc. (GILD), Johnson & Johnson (JNJ)
Gilead Sciences, Inc. (NASDAQ:GILD)' sofosbuvir with Johnson & Johnson (NYSE:JNJ) and Medivir's simeprevir are a match made in heaven.
Is Gilead Sciences, Inc. (GILD) Destined for Greatness?
Every investor can appreciate a stock that consistently beats the Street without getting ahead of its fundamentals and risking a meltdown.
This Week in Biotech: VIVUS, Inc. (VVUS), Roche Holdings Ltd-Spons Adr (RHHBY)
With the SPDR S&P Biotech Index up 25% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
3 Humongous Health-Care Stocks This Week: Infinity Pharmaceuticals Inc. (INFI)
There's power in positive thinking. The late author Norman Vincent Peale made plenty of money off that philosophy.
